Physicochemical Properties, Stabilities and Pharmacokinetics of Cephalosporin 3'-Quinolone Dithiocarbamate

세팔로스포린 3'-퀴놀론의 물리화학적 성질, 안정성 및 체내약물동태

  • Published : 1993.12.01

Abstract

A cepfialosporin with an aminothiazoiylmethoxyimino-type side chain at the 7 position and bicyclic quinolone dithicarbamate at the 3' position was synthesized. It has broad and potent antivacterial activity in vitro. The antibacterial spectrum reflects contributions of both the cephalosporin moiety and the quinolone moiety. Thus, this compound was named DACD implying a dualaction cephalosporin derivative. In this paper, the physicochemical proper-ties (lipid-water partition, pKa), stability and pharmacokinetics of DACD were determined and compared with cefotaxime 3'-norfloxacin dithiocarbamate (CENO). Stability tests were studied in pH 1.20, 6.80 and 8.00 buffers and in the presence of AB type human plasma, rat liver homogenate and its .betha.-lactamase. The pharmacokinetic parameters of DACD were evaluated in mice after a single intravenous dose of 40 mg/kg. The results are as follows. The lipid-water partition coefficient of DACD was higher than that of CENO. The calculated pKa values of CENO and DACD, were 6.82$\pm$0.03, 7.53$\pm$0.21, respectively. In the hydrolysis test, half-lives (t$^{1/2}$) of CENO and DACD was 66.0 hr and 80.0 hr in pH 6.80 buffer, 190 hr and 91.4 hr in pH 8.00 buffer. CENO and DACD were rapidly hydrolyzed in human plasma and in rat liver hornogenate. Half-lives (t$_{1/2}$ of CENO and DACD were 1.29 hr and 1.15 hr in hyman plasma, 0.62 hr and 0.71 hr rat liver homogenate. In $\beta$-lactamase stability test, CENO and DACD were very stable to the .betha.-lactamases obtained from three different strains. Half-life (t$_{1/2}$) and areas under the curve (AUC) in mice were 2.33 hr and 15.97 (mg.h/1), respectively.

Keywords

References

  1. YAKHAK HOEJI v.37 Synthesis and Antibaterial Activity of Cefotaxime 3'-Quinolone Dithiocarbamate La,S.B.;Jung,M.H.;Kim,W.J.;Jee,U.K.
  2. J. Pharm. Sci. v.67 GI Absorption of β-Lactam Antibiotics Ⅱ: Deviation from pH-Partitionypothesis in Penicillin Absorption through In Situ and In vitro Lipoidal Barriers Tsuji,A.;Miyamoto,E.;Hashimoto,N.;Yamana,T.
  3. J. Pharm. Sci. v.68 GI Absotption of β-Lactam Antiviotics Ⅲ: Kinetic Evidence for In Situ Absorption of Ionized Species of Monobasic Penicillins and Cefazolin from the Rat Small Intestine and Structure-Absorption Rate Relationships Tsuji,A.;Miyamoto,E.;Kubo,O.;Yamana,T.
  4. J. Pharm. Sci. v.71 Precise High-Performance Liquid Chromatographic Procedure for the Determination of Cefsulodin, a New Antipseudomonal Cephalosporin Antibiotic, in Plasma Granneman,G.R.;Sennello,L.T.
  5. J. Pharm. Sci. v.78 Ion-Paired Reversed-Phase High-Performance Liquid Chromatography Assay for Determination of Ceftriaxone in Human Plasma and Urine Jungbluth,G.L.;Juslo,W.J.
  6. J. Antibiot. v.29 Ceftezole, a new Cephalosporin C DerivativeⅠ. In Vitro and In Vitro Antimicrobial Activity. Noto,T.;Nehashi,T.;Endo,H.;Saito,M.;Matsubara,S.;Harada,Y.;Suzuki,S.;Ogawa,H.;Koyama,K.
  7. Antimicrob. Agents Chemother. v.18 Induction of β-Lactamase by Various β-Lactam Antibiotics in Enterobacter closcae Minami,S.;Yotsuji,A.;Inoue,M.;Mitsuhashi,S.
  8. Antimicrob. Agents Chemother. v.18 Purification and Properties of Cephalosporinase in Escherichia coli Minami,S.;Inoue,M.;Mitsuhashi,S.
  9. J. Genegal Microbiol. v.121 Purfication and Properties of Chromosomally Mediated β-Lactamase from Citrobater freundii GN7391 Tajima,M.;Takenouchi,Y.;Sugawara,S.;Inoue,M.;Mitsuhashi,S.
  10. Analytical Biochem. v.63 A Direct Spectrophotometeric Assay and Determination of Michaelis Constants for the β-Lactamase Reaction Samuni,A.
  11. J. Antibiot. v.37 Cefodizime, and aminothiazolyl cephalosporin. Ⅱ Comparative studieds on the pharmacokinetic behavior in laboratory animals Klessel,N.;Limbert,M.;Seeger,K.;Seiber,G.;Winkler,I.;Schrinner,E.
  12. Antimicrob. Agents Chemother. v.35 Antibacterial activities in vitro and pharmackinetics of cefqinome(HR ⅢⅤ), a new broad-spectrum cephalosporin Limbert,M.;Isert,D.;Klesel,N.;Markus,A.;Seeger,K.;Seibert,G.;Schrinner,E.
  13. YAKHAK HOEJI v.37 Synthesis and Antibacterial Activities of New Oral Cephalosporins La,S.B.;Jung,M.H.;Kim,W.J.;Jee,U.K.
  14. THE BETA-LACTAM ANTIBIOTICS: Penicillins and Cephalosporins in Perspective Selwyn,S.(ed.)
  15. Antimicrob. Agents Chemother. v.34 Pharmacokinetics of Ro 23-9424, a Dual-Action Cephalosporin, in Animals Christenson,J.G.;Chan,K.K.;Cleeland,R.;Holzknecht,B.D.;Farrish,H.H.Jr.;Patel,L.H.;Specian,A.